My development of a novel HPLC method for impurity profiling of a critical oncology drug candidate at Bristol Myers Squibb accelerated analysis throughput by 30%, significantly reducing the time-to-result for critical release testing batches. This achievement was particularly impactful given the high volume of samples and the stringent regulatory requirements for oncology products, where rapid and accurate characterization directly influenced production timelines and patient access. My approach involved optimizing gradient elution parameters and detector wavelengths, leading to superior resolution and sensitivity compared to the existing method, which struggled with co-eluting peaks.
During my tenure, I leveraged LC-MS/MS to identify and quantify trace impurities in a complex API matrix, resolving a significant quality control bottleneck that previously delayed batch release by 72 hours. I also spearheaded dissolution studies using UV-Vis spectroscopy for three distinct drug delivery systems, informing critical adjustments that improved drug release profiles by an average of 15% for oral solid dosages. Furthermore, I conducted comprehensive solid-state characterization via XRPD and DSC for polymorph screening, providing data that informed the selection of the most stable API form, mitigating potential manufacturing scale-up risks and ensuring product stability.
Novagen Therapeutics' pioneering work in sustained-release drug delivery systems, particularly your recent breakthroughs in polymer-based matrices, deeply resonates with my expertise. My ability to develop highly robust dissolution methods and my extensive experience in solid-state characterization using XRPD and DSC would be directly applicable to ensuring the stability and controlled release kinetics of your advanced formulations. I am keenly interested in contributing my analytical rigor to your innovative projects, especially those focused on enhancing patient adherence and therapeutic outcomes through novel delivery platforms.
My background in advanced analytical techniques and experience managing complex R&D projects aligns precisely with the demands of a Pharmaceutical Scientist at Novagen Therapeutics. I am confident I can contribute significantly to your pipeline, driving both innovation and efficiency in drug development and characterization. I look forward to the opportunity to discuss how my skills and experiences can benefit your team and support Novagen Therapeutics' mission to deliver groundbreaking therapies.
Best regards,
Jordan Reed